Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy

Overview of attention for article published in Applied Immunohistochemistry & Molecular Morphology, April 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

patent: 11 patents

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 11 patents that reference this research output.

Compositions and methods for TCR reprogramming using fusion proteins

Grant US-11965012-B2

United States of America

23 Apr 2024

Compositions and methods for TCR reprogramming using fusion proteins

Grant US-11851491-B2

United States of America

26 Dec 2023

Compositions and methods for TCR reprogramming using fusion proteins

Grant US-11377638-B2

United States of America

05 Jul 2022

Compositions and methods for TCR reprogramming using fusion proteins

Grant US-11242376-B2

United States of America

08 Feb 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 7 additional patents.